Flovent
PATIENT INFORMATION
Patients being treated with FLOVENT Inhalation Aerosol should receive the following information and instructions. This information is intended to aid them in the safe and effective use of this medication. It is not a disclosure of all possible adverse or intended effects.
Patients should use FLOVENT Inhalation Aerosol at regular intervals as directed. Results of clinical trials indicated significant improvement may occur within the first day or two of treatment; however, the full benefit may not be achieved until treatment has been administered for 1 to 2 weeks or longer. The patient should not increase the prescribed dosage but should contact the physician if symptoms do not improve or if the condition worsens.
After inhalation, rinse the mouth with water without swallowing.
Patients should be warned to avoid exposure to chickenpox or measles and, if they are exposed, to consult the physician without delay.
For the proper use of FLOVENT Inhalation Aerosol and to attain maximum improvement, the patient should read and follow carefully the Patient s Instructions for Use accompanying the product.
Generic Name: Fluticasone Propionate
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.
Health Extras
Asthma and Ozone
Researchers are trying to find out exactly why ozone has an impact on asthma and what to do about it. See more WebMD Videos »
Flovent
Related Drugs
Health Resources
Updated & New
RxList does not provide medical advice, diagnosis or treatment.